Skip to main content
KindleeRx logoStart
AI illustration of a folded towel, a cotton shirt and an unlabeled tube on a bathroom bench.

AI-generated illustration. Not an actual patient or treatment result.

PsoriasisNovember 19, 2026 · 10 min read

Inverse and Genital Psoriasis: Which Creams Are Safe for Skin Folds?

Dr. Brandon Kirsch
Dr. Brandon Kirsch, MD, FAAD

Chief Medical Officer

The safest creams for skin folds and genitals are a short course of a low-potency steroid, followed by a steroid-free cream such as roflumilast, tacrolimus or pimecrolimus for longer care. Roflumilast 0.3% cream is approved by the Food and Drug Administration (FDA) for psoriasis including skin folds, and in its two trials 71.5% and 67.5% of patients with fold psoriasis reached clear or almost clear at 8 weeks, vs 13.8% and 17.4% on vehicle (Zoryve cream label). Super-potent steroids such as clobetasol are labeled to stay off the groin and armpits.

In this article

What is inverse psoriasis?

Inverse psoriasis is psoriasis in the body's skin folds. A National Psoriasis Foundation (NPF) consensus lists the folds involved: armpits, groin and genitals, under the breasts, between the buttocks, around the anus, belly folds and behind the ears (Khosravi 2017). In three U.S. cohorts, 21% to 30% of people with psoriasis reported it (Merola 2016). A systematic review of 14 studies describes fold skin as sensitive, thin and naturally occluded, which is why treatment differs from elbows and knees (Reynolds 2020). If you are unsure the rash is psoriasis at all, my eczema vs psoriasis guide covers the differences.

How common is genital psoriasis?

Common, and often missed. In a French study of 776 people seen for psoriasis elsewhere on the body, 335 (43.2%) had genital involvement, yet only 40% of those 335 had ever had their genitals examined (Larsabal 2019). Itching was the main symptom, and genital psoriasis was linked to worse quality of life and sexual health. A Chinese hospital study of 7032 people found genital involvement in 12.00% (Lu 2025); the two studies used different settings and definitions. In the roflumilast cream trials, 13% to 18% of patients had genital psoriasis at the start (Lebwohl 2022). If you have psoriasis anywhere and itching in the groin, say so at your visit.

Which creams are safe for skin folds and the genital area?

Lower-potency steroids for short courses, then steroid-free creams. In 2009 the NPF Medical Board recommended low- to mid-potency steroids for 2 to 4 weeks, and calcipotriene, pimecrolimus or tacrolimus for long-term care (Kalb 2009); its 2017 update keeps low-potency steroids for short-term use (Khosravi 2017). The American Academy of Dermatology (AAD) pathway suggests lower-potency steroids for up to 4 weeks, or off-label tacrolimus 0.1% for up to 8 weeks or pimecrolimus for 4 to 8 weeks (AAD pathway). Tacrolimus 0.1% ointment cleared or almost cleared face or fold psoriasis in 65.2% vs 31.5% on vehicle (Lebwohl 2004). Roflumilast 0.3% cream is labeled for folds from age 2 (Zoryve cream label). My plan: a mild steroid to calm a flare, then a steroid-free cream to keep it calm.

How do the skin-fold treatments compare?

These results come from different trials with different endpoints and lengths, so they cannot be compared head to head.

TreatmentResult in skin-fold psoriasisStatus for psoriasis
Roflumilast 0.3% cream (Zoryve)71.5% and 67.5% clear or almost clear vs 13.8% and 17.4% on vehicle, 8 weeksApproved, skin folds included, age 2 and up
Tacrolimus 0.1% ointment65.2% vs 31.5% clear or almost clear (face or folds), 8 weeksOff-label; boxed warning
Pimecrolimus 1% cream54% vs 21% clear or almost clear at week 2; 71% at week 8Off-label; boxed warning
Betamethasone valerate 0.1% (mid-potency steroid)86.4% drop in severity score vs 21.1% on vehicle, 4 weeksShort courses only
Calcipotriol 0.005%62.4% drop in severity score, 4 weeksCan irritate surrounding skin
Tapinarof 1% cream (Vtama)24 of 29 (83%) clear or almost clear, 12 weeks, open label, no vehicle groupApproved for plaque psoriasis in adults

Sources for the table: Zoryve cream label, Lebwohl 2004, Gribetz 2004, Kreuter 2006, NCT05680740 and the Vtama label. In the 4-week head-to-head trial, pimecrolimus was the weakest active cream, with a 39.7% drop (Kreuter 2006).

Why are strong steroids risky in skin folds?

Fold skin thins more easily, and the fold itself traps the medicine. Steroid labels warn that the face, groin and armpits are more prone to steroid-induced skin thinning (clobetasol solution label). Occlusion raises absorption: the clobetasol label notes that 96 hours under occlusion markedly increases hydrocortisone penetration, and it bars clobetasol from the groin, armpits and occlusive dressings (clobetasol label). Fold skin is naturally occluded (Reynolds 2020). In 12 volunteers, twice-daily clobetasol thinned the test skin by about 15% in 16 days (Lubach 1995), and medium-to-high potency steroids measurably thinned skin from day 8 (Queille-Roussel 2001). I keep super-potent steroids out of folds.

Does Zoryve work for inverse psoriasis?

Yes. Zoryve (roflumilast 0.3% cream), a phosphodiesterase-4 (PDE4) inhibitor, is FDA-approved for plaque psoriasis including intertriginous areas, meaning skin folds, from age 2 (Zoryve cream label). Among patients with fold psoriasis, 71.5% vs 13.8% (DERMIS-1) and 67.5% vs 17.4% (DERMIS-2) reached clear or almost clear at 8 weeks; this subgroup was about 22% and 19% of patients. Across both trials (all body sites), application-site pain was 1.0% vs 0.3% on vehicle. The manufacturer lists skin folds and external genital areas such as the groin as use sites (Zoryve application page), and both the label and the site say not to use it in the eyes, mouth or vagina. It is contraindicated with moderate or severe liver impairment (Zoryve cream label).

What should you avoid putting on skin folds and genitals?

Avoid super-potent steroids, leave-on coal tar and any strong steroid under a dressing. Over-the-counter coal tar creams, ointments and lotions must carry a warning against use in the genital area or groin unless a doctor advises it (21 CFR 358.750). Calcipotriene can irritate both plaques and the normal skin around them (calcipotriene cream label). Tacrolimus and pimecrolimus carry a boxed warning that long-term safety is not established, with rare reports of skin cancer and lymphoma (pimecrolimus label). Roflumilast is not for use in the eyes, mouth or vagina, and while breastfeeding it should not go on the nipple or areola (Zoryve cream label).

How does KindleeRx treat psoriasis?

Through the KindleeRx psoriasis treatment program, licensed clinicians (physician assistants and nurse practitioners working under a board-certified dermatologist's protocols) review each case online and reply in under 5 hours on average. For mild to moderate psoriasis, when a clinician decides it is appropriate, they may prescribe the Calming Cream, a compounded cream with roflumilast 0.2% and calamine 5% used once daily. The skin-fold results above belong to branded Zoryve and do not describe it. A prescription is never guaranteed; if treatment is not prescribed, the refund is full, including the consultation fee. If weight is part of your picture, read how GLP-1 medications relate to psoriasis.

Important Information

The KindleeRx Calming Cream is a compounded prescription medication containing roflumilast 0.2% and calamine 5%, prepared by a licensed US compounding pharmacy under a licensed prescriber. It is not Zoryve, it is not a generic of Zoryve, and it is not an FDA-approved drug product. Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality. KindleeRx is not affiliated with Arcutis or Zoryve. Published trial data for branded roflumilast (Zoryve) reflect the branded product and the branded concentrations studied in those trials, not this compounded formula. Eligibility is determined by a licensed clinician after reviewing your information. Not all patients qualify. This article is educational and is not medical advice.

Sources

Related Articles